Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 89 (2) , 233-235
- https://doi.org/10.1016/s0090-8258(03)00051-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal MarkersJournal of the American Statistical Association, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markersCancer, 1995
- Serum Half-Life of CA 125 during Early Chemotherapy as an Independent Prognostic Variable for Patients with Advanced Epithelial Ovarian Cancer: Results of a Multicentric Italian StudyGynecologic Oncology, 1995
- The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancerGynecologic Oncology, 1992
- Early serum CA125 response and outcome in epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1990